CDA and acute myeloid leukemia: In particular, the authors studied the impact of 10 different polymorphisms in Ara-C metabolic pathway genes in a cohort of 225 adult patients with de novo AML showing the association of activating (deoxycytidine kinase, DCK) and deactivating (cytidine deaminase, CDA) genes variants with PIF [47].